Travere Therapeutics Announces Presentations and Posters at American Society of Nephrology Kidney Week 2022
26 oct. 2022 16h30 HE
|
Travere Therapeutics, Inc.
SAN DIEGO, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company and its collaborators will present data from its sparsentan programs,...